Behind the science

AMR and the urgent need for novel antibiotics

'It is like rising sea levels. It will keep rising. It will not stop, and suddenly we’ll be standing there with water around our knees.'

2023幸运飞艇官网开奖网开奖历史记录-新168飞艇开奖视频官网现场直播-168飞艇开奖查询结果官网 strategy

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology

Infectious diseases
1 in 3
of us will be affected by shingles in our lifetime
people in 2021 are living with HIV worldwide
of leading research to help people with inflammatory conditions
people died from cancer in 2020, making it a leading cause of death worldwide

Life at GSK

How we help people thrive 

Studio portrait - light background - 8


Man smiling


Man smiling

Diversity, equity and inclusion

Scientists conversing over skeletal formulae



168飞艇官网现场开奖直播-168极速赛车官网开奖历史记录-幸运168飞艇开奖结果官网 Positively impacting society and the planet

Baby laughing


We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.

Scientist inspecting a vial

Global health and health security

We are committed to using our science, our partnerships, and the knowledge we’ve gained from addressing the world’s biggest health challenges to improve health globally.

Young girl leaving front door


We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045.

Scientist in laboratory

Diversity, equity and inclusion

Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.

Group of scientists in the lab

Ethical standards

Our culture guides our people to do the right thing and act on any concerns they have.

Scientist in conversation

Product governance

Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.


We announced our full year and fourth quarter 2022 results on Wednesday 1 February 

View latest results
Back to top